mRNA vaccine and therapeutic manufacturer scaling manufacturing and regulatory compliance
Moderna manufactures mRNA vaccines and therapeutics across infectious disease, cancer, and rare disease indications. The tech stack skews enterprise operations (SAP, Veeva, Kyriba) and infrastructure (Azure, AWS, GCP, VMware) rather than research-stage tools, reflecting a company in manufacturing scale-up and regulatory consolidation. Active adoption of SAP Global Trade Services, RAG, and RPA signals systematic effort to automate compliance workflows and supply-chain processes—a necessary response to ten distinct pain points centered on GXP compliance, audit readiness, and inspection preparation.
Notable leadership hires: Executive Director, Regional Accounts Director, Nonclinical Safety Director, Regulatory Affairs Director, Director National Accounts
Moderna develops and manufactures mRNA-based vaccines and therapeutics. The company operates a global manufacturing footprint with hiring across ten countries (Poland, Australia, UK, US, Spain, Germany, Canada, Japan, Singapore, Italy) and active project work in method qualification, process validation, and tech transfer. Current operational focus spans clinical pharmacology, cGMP system optimization, equipment validation, and digital trade compliance. Manufacturing and research departments represent the largest hiring cohorts, alongside ops and engineering roles focused on infrastructure-as-code and predictive analytics for clinical cost forecasting.
Moderna runs SAP (S/4HANA, Global Trade Services, Ariba, GRC), Veeva for regulatory/clinical data, Kyriba for treasury, JAMF/Intune for endpoint management, and cloud infrastructure on Azure/AWS/GCP. Currently adopting RAG and RPA for workflow automation.
Active projects include method qualification and process validation, predictive analytics for clinical trial costs, GXP system optimization, digital trade compliance, generative AI integration, and leading SAP Global Trade Services integration with S/4HANA and Ariba.
Other companies in the same industry, closest in size